Arkolith/Insider Trading/AARD/Form 4

Lee Tien-Li

Chief Executive Officer, Director, 10% OwnerAardvark Therapeutics, Inc. (AARD) · full profile →Form 4 · filed Sep 16, 2025
Net Buying
Open-Market Buys
$97K
Open-Market Sells
$0
Net Open-Market Flow
$97K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 15, 2025Buy(P)7K$9.51$62K1.5M
Sep 15, 2025Buy(P)4K$9.94$35K1.5M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-204233) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML